aspenpharma.com

Website beoordeling aspenpharma.com

Aspen Pharmacare | Pharmaceutical Company

 Gegenereerd op Maart 12 2026 17:36 PM

Oude statistieken? UPDATE !

De score is 57/100

SEO Content

Title

Aspen Pharmacare | Pharmaceutical Company

Lengte : 41

Perfect, uw title tag bevat tussen de 10 en 70 karakters.

Description

Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets

Lengte : 131

Perfect, uw meta description bevat tussen de 70 en 160 karakters.

Keywords

Erg slecht. We hebben geen meta keywords gevonden in uw website. Gebruik deze gratis online meta tags generator om keywords te genereren.

Og Meta Properties

Goed, uw page maakt gebruik van Og Properties.

Property Content
locale en_US
type website
title Aspen Pharmacare | Pharmaceutical Company
description Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets
url https://www.aspenpharma.com/
site_name Aspen Pharmacare
image https://www.aspenpharma.com/wp-content/uploads/2023/02/aspen-pharma-vials-home-1.png
image:width 496
image:height 656
image:type image/png

Headings

H1 H2 H3 H4 H5 H6
0 62 65 10 60 30
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Healthcare. We Care.
  • [H2] Investor Hub
  • [H2] Stephen Saad (61)
  • [H2] Sean Capazorio (60)
  • [H2] Reginald Haman (52)
  • [H2] Kuseni Dlamini 58
  • [H2] Ben Kruger (66)
  • [H2] Linda de Beer (56)
  • [H2] Neo Dongwana (53)
  • [H2] Themba Mkhwanazi (56)
  • [H2] Chris Mortimer (65)
  • [H2] Yvonne Muthien (69)
  • [H2] David Redfern (59)*
  • [H2] Raeesa Khan (35)
  • [H2] Stephen Saad (61)
  • [H2] Gus Attridge (64)
  • [H2] Sean Capazorio (60)
  • [H2] Lorraine Hill (62)
  • [H2] Reginald Haman (51)
  • [H2] Samer Kassem (51)
  • [H2] Pauline Macdonald (49)
  • [H2] Trevor Ziman (54)
  • [H2] Chris Botha (47)
  • [H2] Raeesa Khan (35)
  • [H2] Stavros Nicolaou (60)
  • [H2] Carnie van der Linde (56)
  • [H2] Aspen Key Facts
  • [H2] Latest News
  • [H2] Our Purpose
  • [H2] Our Vision
  • [H2] Our Values
  • [H2] About Aspen
  • [H2] We Care
  • [H2] Careers
  • [H2] Contact Us
  • [H2] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.
  • [H2] Corporate
  • [H2] View our teams below:
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.
  • [H3] Healthcare. We Care. Excellence Integrity Healthcare. We Care. Innovation Commitment Teamwork
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] FY2026 Interim Results Booklet
  • [H3] FY2026 Interim Results Short Form Announcement
  • [H3] Our Heritage
  • [H3] Fact Sheet
  • [H3] Interim Results Presentation
  • [H3] Illustrative Revenue Disclosure
  • [H3] Interim Results Booklet
  • [H3] Interim Results Booklet – Excel Download
  • [H3] Interim Results Presentation Webcast
  • [H3] Interim Results Short Form Announcement
  • [H3] Stakeholder Update Call Presentation 15 January 2026
  • [H3] Stakeholder Update Call Webcast 15 January 2026
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Social and Ethics Committee Report
  • [H3] Notice of AGM
  • [H3] Integrated Report
  • [H3] Audit & Risk Committee Report
  • [H3] Integrated Report – View Online Version
  • [H3] Carbon Disclosure Project – Climate Change and Water Security
  • [H3] Equity Report – Pharmacare Workforce Profile
  • [H3] IBIS Assurance Statement
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Sustainability Materiality Assessment
  • [H3] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H3] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H3] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H3] Aspen highlights the rising diabetes disease burden
  • [H3] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H3] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H3] Aspen delivers strong results and advances its strategic ambitions
  • [H3] Aspen announces local availability of Lilly’s Mounjaro
  • [H3] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H3] Aspen to participate in the Investec CEO conference in London
  • [H3] Aspen Ireland gets recognised for their efforts in diversity
  • [H3] Shining the spotlight on trailblazers in Science this International Women’s Day
  • [H3] Aspen North America Region’s Aspen Canada certified as a Great Place to Work®
  • [H3] Aspen continues to demonstrate its unwavering commitment to our various communities
  • [H3] Aspen partners with Reach for a Dream to bring joy to children with rare diseases 
  • [H3] Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status
  • [H3] Aspen recognised for EY Excellence in Integrated Reporting Award
  • [H3] Closed Period
  • [H4] Board of Directors
  • [H4] Group Executive Committee
  • [H4] Financial Results
  • [H4] Integrated Reporting
  • [H4] Sustainability Documents
  • [H4] Interim Results
  • [H4] Additional Presentations and webcasts
  • [H4]  
  • [H4] Annual Financial Statements
  • [H4] Access to Medicines Position Paper
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] Stephen Saad(61)
  • [H5] Sean Capazorio(60)
  • [H5] Reginald Haman(52)
  • [H5] Kuseni Dlamini(58)
  • [H5] Ben Kruger(66)
  • [H5] Linda de Beer(56)
  • [H5] Neo Dongwana(53)
  • [H5] Themba Mkhwanazi(56)
  • [H5] Chris Mortimer(65)
  • [H5] Yvonne Muthien(69)
  • [H5] David Redfern(59)
  • [H5] Raeesa Khan(35)
  • [H5] Stephen Saad(61)
  • [H5] Gus Attridge(64)
  • [H5] Sean Capazorio(60)
  • [H5] Lorraine Hill(62)
  • [H5] Reginald Haman(52)
  • [H5] Samer Kassem(51)
  • [H5] Pauline Macdonald(49)
  • [H5] Trevor Ziman(54)
  • [H5] Chris Botha(47)
  • [H5] Raeesa Khan(35)
  • [H5] Stavros Nicolaou(60)
  • [H5] Carnie van der Linde(56)
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Find out more
  • [H6] To improve the health and quality of life of patients.
  • [H6] Find out more
  • [H6] To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.
  • [H6] Find out more
  • [H6] Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

Afbeeldingen

We vonden 91 afbeeldingen in de pagina.

51 alt attributen ontbreken. Voeg alternatieve text toe zodat zoekmachines beter kunnen beoordelen wat het onderwerp van de afbeeldingen is.

Text/HTML Ratio

Ratio : 13%

De ratio van text tot HTML code is below 15 procent, dit betekent dat uw pagina waarschijnlijk meer tekst nodig heeft.

Flash

Perfect, geen Flash content gevonden in uw website.

Iframe

Perfect, er zijn geen Iframes in uw website aangetroffen.

Herschreven URL

Perfect. Uw links zien er vriendelijk uit!

Underscores in de URLs

Perfect! Geen underscores gevonden in uw URLs.

In-page links

We vonden een totaal van 92 links inclusie 0 link(s) naar bestanden

Ankertekst Type samenstelling
About Aspen Intern doFollow
Corporate Governance Intern doFollow
Regional Overview Intern doFollow
Manufacturing Intern doFollow
Interim Results Presentation Webcast Intern doFollow
FY2026 Interim Results Presentation Intern doFollow
Investor Relations Intern doFollow
Careers Intern doFollow
Aspen Holding News Intern doFollow
Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment Intern doFollow
Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion Intern doFollow
Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award Intern doFollow
Aspen highlights the rising diabetes disease burden Intern doFollow
Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified Intern doFollow
Aspen celebrates 15 years of commitment to Nelson Mandela Day Intern doFollow
Aspen delivers strong results and advances its strategic ambitions Intern doFollow
Aspen announces local availability of Lilly’s Mounjaro Intern doFollow
Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day Intern doFollow
Aspen to participate in the Investec CEO conference in London Intern doFollow
Aspen partners with PinkDrive to mobilise cancer screening Intern doFollow
Aspen’s revenue increases 10% underpinned by a strong second half performance Intern doFollow
Contact Us Intern doFollow
FY2026 Interim Results Booklet Intern doFollow
FY2026 Interim Results Short Form Announcement Intern doFollow
Fact Sheet Intern doFollow
Interim Results Presentation Intern doFollow
Illustrative Revenue Disclosure Intern doFollow
Interim Results Booklet Intern doFollow
Interim Results Booklet – Excel Download Intern doFollow
Interim Results Presentation Webcast Intern doFollow
Interim Results Short Form Announcement Intern doFollow
Stakeholder Update Call Presentation 15 January 2026 Intern doFollow
Stakeholder Update Call Webcast 15 January 2026 Intern doFollow
Annual Financial Statements Intern doFollow
Sustainability and ESG Data Supplement Intern doFollow
Social and Ethics Committee Report Intern doFollow
Notice of AGM Intern doFollow
Integrated Report Intern doFollow
Audit & Risk Committee Report Intern doFollow
Integrated Report – View Online Version Intern doFollow
Access to Medicines Position Paper Intern doFollow
Carbon Disclosure Project – Climate Change and Water Security Intern doFollow
Equity Report – Pharmacare Workforce Profile Intern doFollow
IBIS Assurance Statement Intern doFollow
Sustainability Materiality Assessment Intern doFollow
Aspen Ireland gets recognised for their efforts in diversity Intern doFollow
Shining the spotlight on trailblazers in Science this International Women’s Day Intern doFollow
Aspen North America Region’s Aspen Canada certified as a Great Place to Work® Intern doFollow
Aspen continues to demonstrate its unwavering commitment to our various communities Intern doFollow
Aspen partners with Reach for a Dream to bring joy to children with rare diseases  Intern doFollow
Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status Intern doFollow
Aspen recognised for EY Excellence in Integrated Reporting Award Intern doFollow
Disclaimer Intern doFollow
General Privacy Notice Extern doFollow
Aspen PAIA & POPI Manual Extern doFollow
Standard Terms of purchase of goods or services (STC) Extern doFollow
Australia Intern doFollow
China Extern doFollow
New Zealand Extern doFollow
Philippines Extern doFollow
Austria Extern doFollow
France Extern doFollow
France – NDB Extern doFollow
Netherlands Extern doFollow
Netherlands – Oss Extern doFollow
Russia Extern doFollow
Spain Extern doFollow
Switzerland Extern doFollow
MENAT Extern doFollow
Canada Extern doFollow
USA Extern doFollow
Brazil Intern doFollow
Mexico Extern doFollow
Ghana Extern doFollow
Kenya Extern doFollow
Mauritius Extern doFollow
Nigeria Extern doFollow
South Africa – SA Commercial Extern doFollow
South Africa – FCC Extern doFollow
South Africa HQ Extern doFollow
Tanzania Extern doFollow
EME Extern doFollow
France Extern doFollow
Germany Extern doFollow
Human Capital Intern doFollow
Legal Intern doFollow
Supply Chain Intern doFollow
Treasury Intern doFollow
Ethics & Compliance Intern doFollow
Risk & Sustainability Intern doFollow
Digital Technology Intern doFollow
Tax Intern doFollow

SEO Keywords

Keywords Cloud

business read qualifications aspen appointed more group executive classification results

Keywords Consistentie

Keyword Content Title Keywords Description Headings
aspen 61
group 41
more 35
appointed 29
read 27

Bruikbaarheid

Url

Domein : aspenpharma.com

Lengte : 15

Favicon

Goed, uw website heeft een favicon.

Printbaarheid

Geweldig. We vonden Print-Vriendelijke CSS.

Taal

Goed. Uw ingestelde taal is en.

Dublin Core

Deze pagina maakt geen gebruik van Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Uw ingestelde Charset is UTF-8.

W3C Validiteit

Fouten : 0

Waarschuwingen : 0

E-mail Privacy

Geweldig er is geen e-mail adres gevonden als platte tekst!

Niet ondersteunde HTML

Geweldig! We hebben geen niet meer ondersteunde HTMl tags gevonden in uw HTML.

Speed Tips

Geweldig, uw website heeft geen tabellen in een tabel.
Jammer, uw website maakt gebruik van inline styles.
Jammer, uw website heeft teveel CSS bestanden (meer dan 4).
Jammer, uw website heeft teveel JS bestanden (meer dan 6).
Perfect, uw website haalt voordeel uit gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimalisatie

XML Sitemap

Geweldig, uw website heeft een XML sitemap.

https://www.aspenpharma.com/sitemap_index.xml

Robots.txt

https://aspenpharma.com/robots.txt

Geweldig uw website heeft een robots.txt bestand.

Analytics

Ontbrekend

We hadden niet op te sporen van een analytics tool op deze website geplaatst.

Web Analytics laat u toe de bezoekersactiviteit op uw website te meten. U zou minstens 1 Analytics tool geïnstalleerd moeten hebben en een extra tool voor de bevestiging van de resultaten.

PageSpeed Insights

Device
Categorieën

Free SEO Testing Tool

Website review is een gratis tool waarmee u eenvoudig uw website kunt analyseren